Depression Study In Elderly Patients

Completed · Phase 3

Conditions studied: Depressive Disorder, Major, Major Depressive Disorder (MDD)

In brief

Major Depressive Disorder (MDD) Study in Elderly Outpatients

Key facts

Study ID

NCT00067444

Run by

GlaxoSmithKline

People needed

560

Starts

2003-06-01

Expected to finish

2005-01-01

Last updated by the study team

2016-09-01

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Major Depressive Disorder (MDD).
• Current major depressive episode at screen at least 2 months duration.
• Must be at least 60 years of age.

You may not qualify if…

• Patients with a primary diagnosis other than MDD.
• Patients with a history of schizophrenia, schizoaffective disorder, bipolar disorder or dementia.
• Patients with a history of brief depressive episodes lasting less than 8 weeks.
• Patients receiving formal psychotherapy within 12 weeks of study.
• Patients who are suicidal.
• Patients who have received electroconvulsive therapy or transcranial magnetic stimulation within 6 months prior to screening.
• Patients with a history or seizure disorders.

Where it is running

• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Anaheim, California, United States
• GSK Investigational Site — Beverly Hills, California, United States
• GSK Investigational Site — El Centro, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Redlands, California, United States
• GSK Investigational Site — Santa Ana, California, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Norwich, Connecticut, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Leesburg, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Orlando, Florida, United States
• GSK Investigational Site — Sebring, Florida, United States
• GSK Investigational Site — St. Petersburg, Florida, United States
• GSK Investigational Site — West Palm Beach, Florida, United States
• GSK Investigational Site — Marietta, Georgia, United States
• GSK Investigational Site — Boise, Idaho, United States
• GSK Investigational Site — Lafayette, Indiana, United States
• GSK Investigational Site — Overland Park, Kansas, United States
• GSK Investigational Site — Prairie Village, Kansas, United States
• GSK Investigational Site — Gaithersburg, Maryland, United States
• GSK Investigational Site — Rockville, Maryland, United States
• GSK Investigational Site — Braintree, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.